ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Hookipa Biotech Initiates First-in-Human Study of Cytomegalovirus Vaccine
September 30, 2018Hookipa Biotech AG, a company pioneering a new class of immunotherapies and vaccines, based on its proprietary viral vector platform Vaxwave®, today announces the start of a first-in-human study to evaluate the safety and immunogenicity of its vaccine can -
Hookipa Biotech raises $60 million in Round C Financing
December 13, 2017All current Hookipa investors, Sofinnova Partners, Forbion Capital Partners, Boehringer Ingelheim Venture Fund, Takeda Ventures and BioMedPartners participated in the round -
Reinhard Kandera Appointed Chief Financial Officer of Hookipa Biotech
April 20, 2017Hookipa Biotech AG, a company pioneering a new class of immunotherapies for oncology and infectious diseases, today announces that Reinhard Kandera has joined the Company as Chief Financial Officer (CFO).
Pharma Sources Insight January 2025
